Skip to content

CTVT - Canine Transmissible Venereal Tumor

CTVT is a cancer that spreads between dogs during mating by transferring living tumor cells. The lineage has survived continuously for thousands of years, making it one of the oldest known somatic cell lineages on Earth.

The basic facts

Genetic studies by Murgia et al. (2006) and Rebbeck et al. (2009) traced all CTVT tumors worldwide back to a single ancestral dog. Using microsatellite markers, they estimated the original tumor arose 200-2,500 years ago from a wolf or East Asian dog breed. More recent genomic analyses suggest it could be even older - potentially over 10,000 years.

Dogs typically live 7-15 years. These cancer cells have outlived their host species by a factor of 1000.

What this tells us about cellular immortality

CTVT proves that cellular immortality isn't just theoretically possible - it's practically achievable and evolutionarily successful. The tumor cells have developed sophisticated mechanisms for long-term survival, immune evasion, and transmission between genetically diverse hosts.

Meanwhile, the cooperative somatic cells that make up normal dog tissues age and die on schedule. This contrast illustrates a fundamental tension in multicellular life: cells that escape the normal constraints can become essentially immortal, while cells that follow the rules are mortal.

The genetic evidence

The uniformity of CTVT is striking. When researchers compared samples from 40 dogs across 5 continents, they found that all tumors were more genetically similar to each other than dogs within the same breed. Of 26 microsatellite markers examined, 21 showed no variation whatsoever across global populations.

This uniformity confirms that CTVT spread through direct cell transmission rather than repeated independent origins. The tumor hasn't just survived - it has maintained genetic integrity while accumulating far more mutations than typical human cancers.

Evolutionary implications

CTVT represents what happens when cells opt out of the multicellular contract. Normal dog somatic cells cooperate for the organism's benefit and accept death as part of that arrangement. CTVT cells have reverted to a more primitive strategy focused purely on their own survival and propagation.

From the cell's perspective, this is evolutionary success. From the organism's perspective, it represents a breakdown in cellular cooperation - the kind of breakdown that multicellular organisms have evolved elaborate mechanisms to prevent.

Research applications

CTVT serves as a natural experiment in several important areas:

  • Long-term cellular evolution under selection pressure
  • Mechanisms of immune evasion across genetic backgrounds
  • The relationship between genomic instability and cellular immortality
  • Trade-offs between cellular autonomy and organismal cooperation

The tumor's longevity also makes it valuable for studying how cells maintain function over evolutionary timescales while accumulating massive genomic changes.

CTVT isn't unique in achieving transmissible immortality. Other examples include:

  • DFTD - Tasmanian Devil Facial Tumor Disease (40+ years old)
  • HeLa - Human immortal cell line (70+ years old)

Each represents the same fundamental pattern: cells that have escaped normal multicellular constraints and achieved individual immortality at the expense of their host organisms.


CTVT shows us what cellular immortality looks like in practice. The results are evolutionarily successful from the cell's perspective, but represent a fundamental breakdown in the cooperative arrangements that enable complex multicellular life.